HEADER TRANSFERASE 04-AUG-22 8AN8 TITLE CRYSTAL STRUCTURE OF WILD-TYPE C-MET BOUND BY COMPOUND 7. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 5 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, AC-HELIX, CANCER, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.W.COLLIE REVDAT 4 01-MAY-24 8AN8 1 REMARK REVDAT 3 27-MAR-24 8AN8 1 JRNL REVDAT 2 04-OCT-23 8AN8 1 REMARK HET HETNAM FORMUL REVDAT 2 2 1 ATOM REVDAT 1 31-AUG-22 8AN8 0 JRNL AUTH G.W.COLLIE,L.BARLIND,S.BAZZAZ,U.BORJESSON,I.L.DALE, JRNL AUTH 2 J.S.DISCH,S.HABESHIAN,R.JETSON,P.KHURANA,A.MADIN, JRNL AUTH 3 I.N.MICHAELIDES,L.PENG,A.SNIJDER,C.J.STUBBS JRNL TITL DISCOVERY OF A SELECTIVE C-MET INHIBITOR WITH A NOVEL JRNL TITL 2 BINDING MODE. JRNL REF BIOORG.MED.CHEM.LETT. V. 75 28948 2022 JRNL REFN ESSN 1464-3405 JRNL PMID 35987508 JRNL DOI 10.1016/J.BMCL.2022.128948 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (24-FEB-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 24841 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.244 REMARK 3 R VALUE (WORKING SET) : 0.241 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1256 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.41 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.65 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 466 REMARK 3 BIN R VALUE (WORKING SET) : 0.3580 REMARK 3 BIN FREE R VALUE : 0.3747 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.24 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 31 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4000 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 83 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.58120 REMARK 3 B22 (A**2) : -26.66270 REMARK 3 B33 (A**2) : 9.08150 REMARK 3 B12 (A**2) : -6.92820 REMARK 3 B13 (A**2) : -9.02820 REMARK 3 B23 (A**2) : -8.29760 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.400 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.383 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.283 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.417 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.295 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.855 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.812 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4198 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5701 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1380 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 672 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4198 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 528 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3121 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.91 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8AN8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1292124803. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-SEP-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24844 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 48.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 1.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: EQUIVALENT D1228V ENTRY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.4 M AM SULFATE, PCPT PH 5.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ALA A 1057 REMARK 465 LEU A 1058 REMARK 465 ASN A 1059 REMARK 465 PRO A 1060 REMARK 465 GLU A 1061 REMARK 465 LEU A 1062 REMARK 465 VAL A 1063 REMARK 465 GLN A 1064 REMARK 465 ALA A 1065 REMARK 465 VAL A 1066 REMARK 465 GLN A 1067 REMARK 465 HIS A 1068 REMARK 465 VAL A 1069 REMARK 465 VAL A 1070 REMARK 465 ILE A 1071 REMARK 465 GLY A 1072 REMARK 465 ASP A 1099 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 GLY A 1102 REMARK 465 LYS A 1103 REMARK 465 LEU A 1112 REMARK 465 ASN A 1113 REMARK 465 ARG A 1114 REMARK 465 ILE A 1115 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ILE A 1118 REMARK 465 LYS A 1132 REMARK 465 ASP A 1133 REMARK 465 ARG A 1148 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 465 SER A 1152 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 465 LYS A 1244 REMARK 465 LEU A 1245 REMARK 465 GLY A 1346 REMARK 465 GLY B 1051 REMARK 465 HIS B 1052 REMARK 465 ILE B 1053 REMARK 465 ASP B 1054 REMARK 465 LEU B 1055 REMARK 465 SER B 1056 REMARK 465 ALA B 1057 REMARK 465 ASN B 1100 REMARK 465 ASP B 1101 REMARK 465 GLY B 1102 REMARK 465 LEU B 1112 REMARK 465 ASN B 1113 REMARK 465 ARG B 1114 REMARK 465 ILE B 1115 REMARK 465 THR B 1116 REMARK 465 ASP B 1117 REMARK 465 ILE B 1118 REMARK 465 GLY B 1119 REMARK 465 LEU B 1147 REMARK 465 ARG B 1148 REMARK 465 SER B 1149 REMARK 465 GLU B 1150 REMARK 465 GLY B 1151 REMARK 465 SER B 1236 REMARK 465 VAL B 1237 REMARK 465 HIS B 1238 REMARK 465 ASN B 1239 REMARK 465 LYS B 1240 REMARK 465 THR B 1241 REMARK 465 GLY B 1242 REMARK 465 ALA B 1243 REMARK 465 LYS B 1244 REMARK 465 GLY B 1346 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1104 CG CD CE NZ REMARK 470 GLU A1214 CG CD OE1 OE2 REMARK 470 LYS A1232 CG CD CE NZ REMARK 470 LYS A1259 CG CD CE NZ REMARK 470 ARG A1279 CG CD NE CZ NH1 NH2 REMARK 470 GLU B1061 CG CD OE1 OE2 REMARK 470 GLN B1064 CG CD OE1 NE2 REMARK 470 ASP B1099 CG OD1 OD2 REMARK 470 LYS B1103 CG CD CE NZ REMARK 470 GLU B1120 CG CD OE1 OE2 REMARK 470 MET B1131 CG SD CE REMARK 470 LYS B1132 CG CD CE NZ REMARK 470 LYS B1215 CG CD CE NZ REMARK 470 LYS B1232 CG CD CE NZ REMARK 470 LEU B1245 CG CD1 CD2 REMARK 470 GLN B1258 CG CD OE1 NE2 REMARK 470 LYS B1259 CG CD CE NZ REMARK 470 ARG B1279 CG CD NE CZ NH1 NH2 REMARK 470 PHE B1290 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1203 -1.89 71.04 REMARK 500 ASP A1204 44.29 -153.44 REMARK 500 TYR A1230 -114.39 56.68 REMARK 500 PRO B1060 -6.28 -59.20 REMARK 500 ALA B1065 -34.68 -154.93 REMARK 500 LYS B1132 33.70 -90.22 REMARK 500 ASP B1133 34.36 -155.16 REMARK 500 HIS B1136 139.88 -173.23 REMARK 500 ARG B1203 -9.48 67.66 REMARK 500 ASP B1204 46.03 -145.80 REMARK 500 TYR B1230 -104.17 56.85 REMARK 500 REMARK 500 REMARK: NULL DBREF 8AN8 A 1052 1346 UNP P08581 MET_HUMAN 1052 1346 DBREF 8AN8 B 1052 1346 UNP P08581 MET_HUMAN 1052 1346 SEQADV 8AN8 GLY A 1051 UNP P08581 EXPRESSION TAG SEQADV 8AN8 GLY B 1051 UNP P08581 EXPRESSION TAG SEQRES 1 A 296 GLY HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 2 A 296 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 3 A 296 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 4 A 296 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 5 A 296 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 6 A 296 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 7 A 296 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 8 A 296 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 9 A 296 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 10 A 296 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 11 A 296 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 12 A 296 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 13 A 296 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 14 A 296 VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP LYS SEQRES 15 A 296 GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 16 A 296 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 17 A 296 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 18 A 296 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 19 A 296 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 20 A 296 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 21 A 296 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 22 A 296 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 23 A 296 ILE SER ALA ILE PHE SER THR PHE ILE GLY SEQRES 1 B 296 GLY HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 2 B 296 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 3 B 296 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 4 B 296 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 5 B 296 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 6 B 296 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 7 B 296 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 8 B 296 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 9 B 296 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 10 B 296 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 11 B 296 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 12 B 296 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 13 B 296 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 14 B 296 VAL ALA ASP PHE GLY LEU ALA ARG ASP MET TYR ASP LYS SEQRES 15 B 296 GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 16 B 296 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 17 B 296 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 18 B 296 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 19 B 296 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 20 B 296 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 21 B 296 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 22 B 296 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 23 B 296 ILE SER ALA ILE PHE SER THR PHE ILE GLY HET SO4 A1401 5 HET SO4 A1402 5 HET SO4 A1403 5 HET SO4 A1404 5 HET MDI A1405 34 HET SO4 B1401 5 HET MDI B1402 34 HETNAM SO4 SULFATE ION HETNAM MDI 3-[BIS(FLUORANYL)METHYL]-~{N}-METHYL-~{N}-[(1~{R})-8- HETNAM 2 MDI METHYL-5-(3-METHYL-1~{H}-INDAZOL-6-YL)-1,2,3,4- HETNAM 3 MDI TETRAHYDRONAPHTHALEN-1-YL]PYRIDINE-2-CARBOXAMIDE FORMUL 3 SO4 5(O4 S 2-) FORMUL 7 MDI 2(C27 H26 F2 N4 O) FORMUL 10 HOH *83(H2 O) HELIX 1 AA1 GLY A 1085 HIS A 1088 5 4 HELIX 2 AA2 SER A 1122 MET A 1131 1 10 HELIX 3 AA3 ASP A 1164 ASN A 1171 1 8 HELIX 4 AA4 THR A 1177 LYS A 1198 1 22 HELIX 5 AA5 ALA A 1206 ARG A 1208 5 3 HELIX 6 AA6 PRO A 1246 MET A 1250 5 5 HELIX 7 AA7 ALA A 1251 GLN A 1258 1 8 HELIX 8 AA8 THR A 1261 THR A 1278 1 18 HELIX 9 AA9 ASN A 1288 PHE A 1290 5 3 HELIX 10 AB1 ASP A 1291 GLN A 1298 1 8 HELIX 11 AB2 PRO A 1309 TRP A 1320 1 12 HELIX 12 AB3 LYS A 1323 ARG A 1327 5 5 HELIX 13 AB4 SER A 1329 THR A 1343 1 15 HELIX 14 AB5 ASN B 1059 GLN B 1064 1 6 HELIX 15 AB6 ALA B 1065 VAL B 1070 5 6 HELIX 16 AB7 GLY B 1072 SER B 1074 5 3 HELIX 17 AB8 GLY B 1085 HIS B 1088 5 4 HELIX 18 AB9 SER B 1122 MET B 1131 1 10 HELIX 19 AC1 ASP B 1164 ASN B 1171 1 8 HELIX 20 AC2 THR B 1177 LYS B 1198 1 22 HELIX 21 AC3 ALA B 1206 ARG B 1208 5 3 HELIX 22 AC4 PRO B 1246 MET B 1250 5 5 HELIX 23 AC5 ALA B 1251 GLN B 1258 1 8 HELIX 24 AC6 THR B 1261 THR B 1278 1 18 HELIX 25 AC7 ASN B 1288 PHE B 1290 5 3 HELIX 26 AC8 ASP B 1291 LEU B 1297 1 7 HELIX 27 AC9 PRO B 1309 TRP B 1320 1 12 HELIX 28 AD1 LYS B 1323 ARG B 1327 5 5 HELIX 29 AD2 SER B 1329 THR B 1343 1 15 SHEET 1 AA1 5 LEU A1076 VAL A1083 0 SHEET 2 AA1 5 VAL A1092 LEU A1097 -1 O HIS A1094 N HIS A1079 SHEET 3 AA1 5 ILE A1105 LYS A1110 -1 O ILE A1105 N LEU A1097 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N CYS A1146 O LEU A1154 SHEET 1 AA2 2 PHE A1200 VAL A1201 0 SHEET 2 AA2 2 ARG A1227 ASP A1228 -1 O ARG A1227 N VAL A1201 SHEET 1 AA3 2 CYS A1210 LEU A1212 0 SHEET 2 AA3 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA4 5 LEU B1076 VAL B1083 0 SHEET 2 AA4 5 TYR B1093 LEU B1097 -1 O HIS B1094 N HIS B1079 SHEET 3 AA4 5 ILE B1105 LYS B1110 -1 O ILE B1105 N LEU B1097 SHEET 4 AA4 5 LEU B1154 PRO B1158 -1 O LEU B1157 N ALA B1108 SHEET 5 AA4 5 GLY B1144 CYS B1146 -1 N GLY B1144 O VAL B1156 SHEET 1 AA5 2 PHE B1200 VAL B1201 0 SHEET 2 AA5 2 ARG B1227 ASP B1228 -1 O ARG B1227 N VAL B1201 SHEET 1 AA6 2 CYS B1210 LEU B1212 0 SHEET 2 AA6 2 VAL B1218 VAL B1220 -1 O LYS B1219 N MET B1211 CRYST1 42.838 52.181 84.074 74.26 77.64 70.55 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023344 -0.008244 -0.003407 0.00000 SCALE2 0.000000 0.020324 -0.004521 0.00000 SCALE3 0.000000 0.000000 0.012474 0.00000